These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2196084)

  • 21. Treatment of psoriasis with cyclosporin. Experience at Johannesburg Hospital.
    Nevin RJ; Schulz EJ
    S Afr Med J; 1995 Nov; 85(11):1165-8. PubMed ID: 8597006
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A consensus report: cyclosporin A therapy for psoriasis.
    Br J Dermatol; 1990 Jun; 122 Suppl 36():1-3. PubMed ID: 2196076
    [No Abstract]   [Full Text] [Related]  

  • 23. Nephrotoxicity in bone marrow transplant recipients treated with cyclosporin A.
    Hows JM; Chipping PM; Fairhead S; Smith J; Baughan A; Gordon-Smith EC
    Br J Haematol; 1983 May; 54(1):69-78. PubMed ID: 6342656
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conversion of psoriasis patients from the conventional formulation of cyclosporin A to a new microemulsion formulation: a randomized, open, multicentre assessment of safety and tolerability.
    Zachariae H; Abrams B; Bleehen SS; Bräutigam M; Burrows D; Ettelt MJ; Fry L; Happle R; Haustein UF; Ganslandt J; Jung EG; Knop J; Kühne KH; Mellein B; Mørk NJ; Rogers S; Schmidt AG; Schopf RE; Sumner M; Taube KM; Weidinger G; Wurdel C; Zahn E
    Dermatology; 1998; 196(2):231-6. PubMed ID: 9568413
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term cyclosporin for psoriasis.
    Griffiths CE; Powles AV; McFadden J; Baker BS; Valdimarsson H; Fry L
    Br J Dermatol; 1989 Feb; 120(2):253-60. PubMed ID: 2923798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of cyclosporin A (CyA) in psoriasis: an overview of dose/response, indications, contraindications and side-effects.
    Zachariae H; Steen Olsen T
    Clin Nephrol; 1995 Mar; 43(3):154-8. PubMed ID: 7774070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 99mTc-DTPA and 131I-hippuran findings in liver transplant recipients treated with cyclosporin A.
    Klintmalm GB; Klingensmith WC; Iwatsuki S; Schröter GP; Starzl TE
    Radiology; 1982 Jan; 142(1):199-202. PubMed ID: 7031760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of cyclosporin in psoriasis.
    Bos JD; Meinardi MM; van Joost T; Heule F; Powles AV; Fry L
    Lancet; 1989 Dec 23-30; 2(8678-8679):1500-2. PubMed ID: 2574777
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclosporin versus methotrexate toxicity in psoriasis.
    Zachariae H; Kragballe K
    Lancet; 1990 Apr; 335(8694):924. PubMed ID: 1970018
    [No Abstract]   [Full Text] [Related]  

  • 30. Cyclosporin A-induced gingival hyperplasia in psoriasis: review of the literature and case reports.
    V'lckova-Laskoska MT
    Acta Dermatovenerol Croat; 2005; 13(2):108-13. PubMed ID: 16324424
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiple squamous cell carcinomas in a psoriatic patient following high-dose photochemotherapy and cyclosporin treatment: response to long-term acitretin maintenance.
    van de Kerkhof PC; de Rooij MJ
    Br J Dermatol; 1997 Feb; 136(2):275-8. PubMed ID: 9068750
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of cyclosporin A pharmacokinetics of a new microemulsion formulation and standard oral preparation in patients with psoriasis.
    Erkko P; Granlund H; Nuutinen M; Reitamo S
    Br J Dermatol; 1997 Jan; 136(1):82-8. PubMed ID: 9039300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclosporin A in atopic dermatitis.
    Ross JS; Camp RD
    Br J Dermatol; 1990 Jun; 122 Suppl 36():41-5. PubMed ID: 2196083
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renal function and biopsy findings after 5 years' treatment with low-dose cyclosporin for psoriasis.
    Powles AV; Cook T; Hulme B; Baker BS; Lewis HM; Thomas E; Valdimarsson H; Fry L
    Br J Dermatol; 1993 Feb; 128(2):159-65. PubMed ID: 8457449
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renal function after long-term low-dose cyclosporin for psoriasis.
    Powles AV; Carmichael D; Hulme B; Thomas E; McFadden J; Baker B; Valdimarsson H; Fry L
    Br J Dermatol; 1990 May; 122(5):665-9. PubMed ID: 2112945
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dermatological aspects of the use of Cyclosporin A for prophylaxis of graft-versus-host disease.
    Harper JI; Kendra JR; Desai S; Staughton RC; Barrett AJ; Hobbs JR
    Br J Dermatol; 1984 Apr; 110(4):469-74. PubMed ID: 6370294
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low-dose cyclosporine A in severe psoriasis.
    Marks J
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):68-71. PubMed ID: 3381305
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Short-term use of cyclosporin A in severe psoriasis.
    Van Joost T; Heule F; Stolz E; Beukers R
    Br J Dermatol; 1986 May; 114(5):615-20. PubMed ID: 3718852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the therapeutic range of whole blood cyclosporin concentration in the treatment of psoriasis.
    Ieiri I; Nakayama J; Murakami H; Hori Y; Higuchi S
    Int J Clin Pharmacol Ther; 1996 Mar; 34(3):106-11. PubMed ID: 8705088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Eosinophils, pruritus and psoriasis: effects of treatment with etretinate or cyclosporin-A.
    Schopf RE; Hultsch T; Lotz J; Bräutigam M
    J Eur Acad Dermatol Venereol; 1998 Nov; 11(3):234-9. PubMed ID: 9883435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.